Correlation Between Teva Pharma and Pulmatrix
Can any of the company-specific risk be diversified away by investing in both Teva Pharma and Pulmatrix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharma and Pulmatrix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharma Industries and Pulmatrix, you can compare the effects of market volatilities on Teva Pharma and Pulmatrix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharma with a short position of Pulmatrix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharma and Pulmatrix.
Diversification Opportunities for Teva Pharma and Pulmatrix
-0.47 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Teva and Pulmatrix is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharma Industries and Pulmatrix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pulmatrix and Teva Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharma Industries are associated (or correlated) with Pulmatrix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pulmatrix has no effect on the direction of Teva Pharma i.e., Teva Pharma and Pulmatrix go up and down completely randomly.
Pair Corralation between Teva Pharma and Pulmatrix
Given the investment horizon of 90 days Teva Pharma Industries is expected to under-perform the Pulmatrix. But the stock apears to be less risky and, when comparing its historical volatility, Teva Pharma Industries is 2.36 times less risky than Pulmatrix. The stock trades about -0.25 of its potential returns per unit of risk. The Pulmatrix is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 629.00 in Pulmatrix on December 5, 2024 and sell it today you would earn a total of 150.00 from holding Pulmatrix or generate 23.85% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Teva Pharma Industries vs. Pulmatrix
Performance |
Timeline |
Teva Pharma Industries |
Pulmatrix |
Teva Pharma and Pulmatrix Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Teva Pharma and Pulmatrix
The main advantage of trading using opposite Teva Pharma and Pulmatrix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharma position performs unexpectedly, Pulmatrix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pulmatrix will offset losses from the drop in Pulmatrix's long position.Teva Pharma vs. Haleon plc | Teva Pharma vs. Bausch Health Companies | Teva Pharma vs. Zoetis Inc | Teva Pharma vs. Takeda Pharmaceutical Co |
Pulmatrix vs. Capricor Therapeutics | Pulmatrix vs. Akari Therapeutics PLC | Pulmatrix vs. Soleno Therapeutics | Pulmatrix vs. Bio Path Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
CEOs Directory Screen CEOs from public companies around the world | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |